About ALIGN-T1D

To address the deadly disparities in access to comprehensive diabetes care, ALIGN-T1D is leveraging collective investments and actions to ensure quality care is available to all people living with T1D.

Vision

A world where all people living with type 1 diabetes have equitable access to type 1 diabetes detection, diagnosis, treatment, education, and care, to live healthy, productive lives.

Mission

To engage with governments and communities in low- and middle-income countries to sustainably enhance access for people living with type 1 diabetes through integrated NCD approaches, and to optimize and mobilize funding towards government- and community-defined priorities.

What ALIGN-T1D Does

ALIGN-T1D is coordinating action across five areas to improve access to comprehensive T1D care:

Strengthening integrated T1D service delivery

Integrating T1D diagnosis, care, and management with broader NCD and primary health care services to increase equity in access to comprehensive care

WHY: 

  • Access to quality T1D care is limited by a shortage of locally available services and trained health care workers, insufficient supplies of diagnostics and medicines at facilities, and a lack of locally tailored guidelines for T1D and NCD management  
  • Supporting the development of locally tailored guidelines for T1D, patient education materials, health care worker training across all levels, and integrating T1D services into existing national programs can ensure sustainable access to quality care for all people living with T1D 

Ensuring better insulin, monitoring, and other supplies access

Supporting health systems to more accurately determine and secure the amount of insulin and supplies their communities need, ensuring sustainable and affordable access for people living with T1D no matter where they live

WHY: 

  • People living with T1D are reliant on an essential package of quality-assured supplies, including insulin, delivery devices, glucometers and test strips. However, the availability and affordability of even an essential package of T1D supplies remains limited in low- and middle-income countries, while high income countries continue to transition to more modern technologies, like continuous glucose monitors.

  • Although donation programs have a positive impact, they don’t provide supplies for all people living with T1D and do not offer a sustainable, long-term solution

  • Supporting sustainable access to affordable diabetes medicines and technology has the potential to restore 20 healthy years of life

Supporting health systems

Ensuring T1D and other NCDs are included in national coordination plans, budgets, financial protection schemes, and data systems to enable sustainable, integrated T1D programs

WHY: 

  • Currently, many health systems in LMICs lack strategic plans and comprehensive data for people living with T1D, which hinder evidence-based care and policymaking

  • Those gaps coupled with the excessive financial burden caused by limited T1D coverage through national insurance or subsidized care plans or insurance and inefficient supply chains, reduce the health systems’ ability to provide quality care for people living with T1D and other NCDs

  • Integrating T1D into proven health systems strengthening approaches is key to tackling these challenges

Amplifying the role of T1D communities

Amplify and elevate the role of T1D communities for peer and community education and support, stigma reduction, and strategic advocacy

WHY: 

  • Due to inadequate support, many people living with T1D in low- and middle-income countries do not know what they need to do to manage their condition

  • Ongoing stigma and misinformation in communities exacerbate this issue and can also lead to discrimination

  • Community-based organizations offer lifesaving services and peer support, but lack the resources to scale these solutions

Mobilizing stakeholders and funding

Establish a platform to mobilize and convene additional public and private stakeholders and funding towards government- and community-defined T1D and NCD priorities

WHY: 

  • Current funding is not optimized with programs often duplicating work or leaving needs unmet

  • Comprehensive T1D care needs to be integrated and aligned with broader health system strengthening funding to best address in-country priorities

How ALIGN-T1D Works

To drive these changes, the Alliance will focus on three bodies of work:

Invest in Countries and Communities

To increase the value-for-money and sustainability of investments, ALIGN-T1D will serve as a platform to bring partners together, optimize existing investments, and close gaps. Country-specific priority-setting will be led by government and community representatives.

Enhance access to insulin, monitoring, and other supplies

Building on country-specific investments, ALIGN-T1D is exploring cross-country solutions to improve the availability and affordability of insulin and blood glucose monitoring supplies for people with T1D in low- and middle-income countries. Solutions will address several country-specific and cross-country barriers that limit access and drive-up costs for people with T1D.

Build Momentum for Global T1D Equity

To elevate T1D priorities in national, regional, and global conversations, ALIGN-T1D plans to enhance coordination and collaboration among partners, convene stakeholders around a shared strategy, and mobilize additional funders.

The Way Forward

Providing access to comprehensive care to people living with T1D where it’s most needed

In its first phase, ALIGN-T1D will:

Partner with 3 low- and middle-income countries

Support diagnosis for an estimated 14,000 people living with T1D

Reach 1 million people who use insulin, including 165,000 people living with T1D

Stay tuned for updates on future phases of the Alliance’s multi-year strategy.

Alliance Principles

ALIGN-T1D's work will be underpinned by four core principles:

Locally led, sustainably built

Community and lived experience driven design

Comprehensive, integrated approach

Coordinated actions, shared accountability

Who We Are

Funded by The Leona M. and Harry B. Helmsley Charitable Trust and Breakthrough T1D, ALIGN-T1D comprises the largest funders of T1D programs in LMICs, some of the world’s leading producers of diabetes medicines and technologies—including Roche and Sanofi’s Global Health Unit—and members of the T1D community.

Scroll to Top